|
CF group |
ZF group |
ZF subgroup adults |
ZF subgroup paediatric |
Number of patients (n) |
280 |
294 |
170 |
124 |
Underage patients (n, %) |
0/280 (0.0) |
124/294
(42.2)*
|
0/170 (0.0) |
124/124
(100)*
|
Female (n, %) |
121/280 (43.2) |
145/294 (49.3) |
76/170 (44.7) |
69/124 (55.6)*
|
Age (years) |
52.7 ± 16.5 |
30.9 ± 20.3*
|
44.1 ± 17.1 |
12.8 ± 3.61*
|
BMI (kg/m2) |
27.0 ± 5.4 |
22.8 ±
5.7*
|
26.0 ± 5.4 |
19.4 ±
3.63*
|
AVNRT (n, %) |
177/280 (63.2) |
156/294 (53.1)*
|
96/170 (56.5) |
60/124 (48.4)*
|
AVRT (n, %) |
66/280 (23.6) |
101/294 (34.4) |
48/170 (28.2) |
53/124
(42.7) |
AT (n, %) |
37/280 (13.2) |
37/294 (12.6) |
26/170 (15.3) |
11/124
(8.9) |
AAD (n, %) |
157/280 (56.1) |
61/294 (20.7)*
|
41/170
(24.1)*
|
20/124
(16.1)*
|
amiodarone (n, %) |
7/280 (2.5) |
2/294 (0.7) |
2/170 (1.2) |
0/124
(0.0) |
nonamiodarone (n, %) |
152/280 (54.3) |
58/294
(19.7)*
|
38/170 (22.4)*
|
20/124
(16.1)*
|
p value a
|
p value
a
|
p value a
|
p value a
|
p value
a
|
|
ZF group |
ZF group |
ZF subgroup adults |
ZF subgroup
paediatric |
Underage patients (n, %) |
<0.001 |
<0.001 |
NA |
<0.001 |
Female (n, %) |
0.143 |
0.143 |
0.757 |
0.021 |
Age (years) |
<0.001 |
<0.001 |
0.758 |
<0.001 |
BMI (kg/m2) |
<0.001 |
<0.001 |
0.052 |
<0.001 |
AVNRT (n, %) |
0.014 |
0.014 |
0.156 |
0.005 |
AVRT (n, %) |
0.004 |
0.004 |
0.270 |
<0.001 |
AT (n, %) |
0.822 |
0.822 |
0.538 |
0.213 |
AAD (n, %) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |
amiodarone (n, %) |
0.078 |
0.078 |
0.328 |
0.075 |
nonamiodarone (n, %) |
<0.001 |
<0.001 |
<0.001 |
<0.001 |